Pankaj Mohan

Pankaj Mohan is a declared insider at 2 companies (chief executive); the most frequent names are Sonnet BioTherapeutics Holdings, Inc. and Outlook Therapeutics, Inc. In total, 21 filings cover trades dated from 11 May 2016 to 11 December 2023.

Both buying and selling appear: 7 purchases worth €163k, against 4 sales worth €213k. The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 8 share grants.

In size, the median ticket on the buying side is €21k. On 4 out of 7 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 5 December 2024: a share grant, in Sonnet BioTherapeutics Holdings, Inc. The most recent open-market purchase was published on 27 October 2023, 1,109 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.